Basic Information

Gene symbol S Synonyms E2 Type of gene protein-coding
Gene perturbation-related omics dataset PerturbAtlas
Description spike glycoprotein

GTO ID GTC3281
Trial ID NCT05658523
Disease COVID-19
Altered gene S
Therapeutic/Target gene Therapeutic gene
TherapymRNA vaccine
Treatment mRNA-1273|Elasomeran|Spikevax
Location approved UK, Canada, Taiwan, Switzerland, Japan, EU, Australia, South Korea, Singapore, US
PhasePhase3
Recruitment statusActive, Not Recruiting
TitleA Randomised Controlled Trial to Assess the Immunogenicity, Safety and Reactogenicity of a Bivalent mRNA Moderna COVID-19 Vaccine or a Protein-based Novavax COVID-19 Vaccine Given as a Fourth Dose in Healthy Adults in Australia
Year2023
CountryAustralia
Company sponsorMurdoch Childrens Research Institute
Other ID(s)91108
Vector information
Vectorlipid nanoparticle

Clinical Result

Cohort1: mRNA-1273.214
Administration route None
Dosage mRNA-1273.214, single standard dose, day 0
Age Adult, Older_Adult
Cohort2: Novavax
Administration route None
Dosage Novavax, single dose, day 0
Age Adult, Older_Adult
Cohort3: no intervention
Administration route None
Age Adult, Older_Adult

Relationship Graph

Overview of Knowledge Graph